Ophthalmology Medical Animations

Eye science at its most stunning. Watch us bring ophthalmology to life in cinematic 3D, supporting education and engagement.

BACK

AFLIBERCEPT MOA: BLOCKADE OF VEGF SIGNALLING IN RETINAL DISEASE

OPEN

CLOSE

This Fusion Animation uses 3D medical animation to detail the Mechanism of Action (MOA) of Aflibercept, a pioneering bispecific fusion protein for retinal diseases like neovascular AMD. We visualize the pathophysiology involving VEGFR-1 and VEGFR-2. The animation demonstrates Aflibercept's superior multi-targeted blockade: it traps all ligands of VEGFR-1 and key ligands of VEGFR-2, providing comprehensive inhibition of vascular leakage and neovascularization. This showcases our expertise in Ophthalmology and Anti-VEGF pharmacology.

0:00

AFLIBERCEPT MOA: BLOCKADE OF VEGF SIGNALLING IN RETINAL DISEASE

This Fusion Animation uses 3D medical animation to detail the Mechanism of Action (MOA) of Aflibercept, a pioneering bispecific fusion protein for retinal diseases like neovascular AMD. We visualize the pathophysiology involving VEGFR-1 and VEGFR-2. The animation demonstrates Aflibercept's superior multi-targeted blockade: it traps all ligands of VEGFR-1 and key ligands of VEGFR-2, providing comprehensive inhibition of vascular leakage and neovascularization. This showcases our expertise in Ophthalmology and Anti-VEGF pharmacology.

OPEN

CLOSE

0:00

OPEN

CLOSE

0:00

Brief: explain the underlying causes of dry eye disease to HCPs.

OPEN

CLOSE

0:00

Brief: explain the underlying causes of dry eye disease to HCPs.

Contact

Please contact us using the details below.

Office

410, Highgate Studios,
53-79 Highgate Road,
London NW5 1TL0

T +44 (0)207 127 6935

+44 (0)207 127 6935

M +44 (0)7970 080 690

+44 (0)7970 080 690

info@fusionanimation.co.uk

info@fusionanimation.co.uk

SOCIAL

Vimeo

Viemo

Instagram

Instagram

LinkedIn

LinkedIn
SUBMIT
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CLOSE